[1]
2016. In Silico Studies of M. Tuberculosis L-Lysine 6- Monooxygenase (Mbtg) as Potential Target and an Approach for Repurposing First Line Antitubercular Oral Drugs. Journal of International Academy of Physical Sciences. 20, 4 (Dec. 2016), 325–335.